European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 15, Status: Authorised

Submitted by Anonymous (not verified) on 4 November 2025 - 16:50

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 15, Status: Authorised

15th industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, from 4 December 2025, 12:30 (CET) to 4 December 2025, 17:30 (CET)

Submitted by Anonymous (not verified) on 4 November 2025 - 16:22

15th industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, from 4 December 2025, 12:30 (CET) to 4 December 2025, 17:30 (CET)

Human medicines European public assessment report (EPAR): Rekambys, rilpivirine, Date of authorisation: 17/12/2020, Revision: 13, Status: Authorised

Submitted by Anonymous (not verified) on 4 November 2025 - 16:15

Human medicines European public assessment report (EPAR): Rekambys, rilpivirine, Date of authorisation: 17/12/2020, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Jivi, damoctocog alfa pegol, Date of authorisation: 22/11/2018, Revision: 7, Status: Authorised

Submitted by Anonymous (not verified) on 4 November 2025 - 15:55

Human medicines European public assessment report (EPAR): Jivi, damoctocog alfa pegol, Date of authorisation: 22/11/2018, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 7, Status: Authorised

Submitted by Anonymous (not verified) on 4 November 2025 - 15:44

Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 7, Status: Authorised

Committee for Advanced Therapies (CAT): 5-7 November 2025, European Medicines Agency, Amsterdam, the Netherlands, from 5 November 2025 to 7 November 2025

Submitted by Anonymous (not verified) on 4 November 2025 - 15:15

Committee for Advanced Therapies (CAT): 5-7 November 2025, European Medicines Agency, Amsterdam, the Netherlands, from 5 November 2025 to 7 November 2025

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness